Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$61.03 - $69.57 $1,830 - $2,087
30 New
30 $2,000
Q1 2019

Apr 04, 2019

SELL
$35.49 - $43.02 $41,878 - $50,763
-1,180 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$28.96 - $34.0 $34,172 - $40,120
1,180
1,180 $40,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Premier Bank Portfolio

Follow First Premier Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.